IC
HELP

Ikarian Capital’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Ikarian Capital’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$874K Hold
132,153
– – 0.09% 111
2026
Q1 		$634K Hold
132,153
– – 0.05% 121
2025
Q4 		$1.08M Sell
132,153
-8,322
-6% -$53.6K 0.08% 125
2025
Q3 		$827K Hold
140,475
– – 0.08% 125
2025
Q2 		$1.18M Sell
140,475
-256,700
-65% -$1.87M 0.23% 80
2025
Q1 		$2.52M Hold
397,175
– – 0.31% 64
2024
Q4 		$3.5M Buy
397,175
+29,980
+8% +$304K 0.48% 58
2024
Q3 		$3.26M Sell
367,195
-2
-0% -$20 0.46% 61
2024
Q2 		$3.78M Hold
367,197
– – 0.66% 37
2024
Q1 		$5.77M Buy
+367,197
New +$5.3M 0.63% 51

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

Ikarian Capital's HELP Position: Q2 2026 in Review

Ikarian Capital held its Helus Pharma Inc. Common Stock (HELP) position steady in Q2 2026 at 132,153 shares worth $874K. The position accounts for 0.09% of the portfolio, ranked #111.

Ikarian Capital first reported a position in HELP in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.77M in Q1 2024. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • Ikarian Capital held 132,153 shares of Helus Pharma Inc. Common Stock worth $874K as of Q2 2026.
  • Ikarian Capital left its Helus Pharma Inc. Common Stock share count unchanged in Q2 2026.
  • Helus Pharma Inc. Common Stock made up 0.09% of Ikarian Capital's portfolio in Q2 2026, its #111 holding.
  • Ikarian Capital first reported a position in Helus Pharma Inc. Common Stock in Q1 2024 and has held it in 10 quarters since.
  • Ikarian Capital's Helus Pharma Inc. Common Stock position peaked at $5.77M in Q1 2024.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.